TEL AVIV, ISRAEL, March 1, 2006 – Compugen Ltd. (NASDAQ: CGEN) announced today that Martin Gerstel, Chairman of the Board, is scheduled to present at the upcoming SG Cowen & Co. 26th Annual Health Care Conference at 11:20 AM (Eastern Time) on Thursday, March 9, 2006 at the Boston Marriott Copley Place in Boston.
A live Webcast of the presentation will be available on the Compugen Website at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CGEN&item_id=1216375.
A replay will be available one hour after the presentation ends and will be accessible for ninety days following the presentation.
Compugen is a biotechnology discovery company focused on therapeutic and diagnostic products. The Company’s powerful predictive models and discovery engines enable the discovery of numerous potential therapeutics and diagnostic biomarkers. This capability results from the Company’s pioneering and on-going incorporation of ideas and methods from mathematics, computer science and physics into biology, chemistry and medicine. To date, Compugen’s discovery efforts have focused mainly on cancer, cardiovascular and immune-related diseases. Product development is pursued both in-house and through collaborative arrangements. The Company’s primary business goal is to out-license therapeutic and diagnostic product candidates for commercialization by leading companies under milestone and revenue sharing agreements. Compugen has established an agricultural biotechnology affiliate – Evogene, and a small-molecule drug discovery affiliate – Keddem Bioscience. For additional information, please visit Compugen’s corporate Website at www.cgen.com.